Last Friday, Allezoe Medical Holdings, Inc (OTC:ALZM) jumped up. After a number of price hesitations, the stock soared 
almost 27% on the market and its traded volume rose up.
According to the recent records, there could be only one reason for the price move – the latest news by Allezoe. On Friday, the company announced some changes in its Board of Directors, along with the appointment of its new CEO Mr. Michael Gelmon.
Obviously, investors were encouraged by the team expansion of ALZM and the stock price immediately jumped up. Now, the question is, will the up move continue?
Allezoe Medical Holdings, Inc is the holding company for Organ Transport Systems, Inc. and for future acquisitions targeted to medical products, solutions and services. As already reported on hotstocked.com, ALZM has been going downhill since April and the only news released lately concerned nothing else but its Board of Directors. Thus, presently no one is familiar with the company’s business projects.[BANNER]
Also, another big issue for Allezoe are its poor financials, which raise plenty of disturbing questions. The company’s last 10-Q shows that as of end-February 2011 ALZM has no revenues and over $2 million in current liabilities, which it cannot cover. If we add the operating loss and the small amount of current assets to the rest of the numbers mentioned here, the situation gets even worse.
In this case, changes in the Board of Directors will hardly help Allezoe implement its future projects, if it has any at all.
